Pancreatic cancer patients have one of the lowest five-year survival rates, due in large part to the disease going undiagnosed in its early and intermediate stages. There are no overt symptoms during the critical early period, and non-invasive screening tools for identifying early pancreatic tumors before they metastasize have yet to be developed (Read more...)